Nearly 50% of US nephrologists are international medical graduates. Their contributions improve the U.S. health system and the care of people with kidney diseases.
ASN firmly supports the dismantling of barriers that prevent foreign-trained doctors, nurses, and other health professionals from securing the stable immigration status and providing care to the millions of Americans who desperately need it.
At ASN Kidney Week 2018’s Opening Plenary Session, Ed Simcox, Chief Technology Officer and Acting Chief Information Officer at the US Department of Health and Human Services, announced that KidneyX: Redesign Dialysis is now accepting applications for its first phase.
In coordination with the University of Washington, Northwest Kidney Centers, and the U.S. Department of Health and Human Services (HHS), the American Society of Nephrology (ASN) hosted a listening session for KidneyX on Wednesday, August 22 in Seattle, WA.
KidneyX, a public private partnership between ASN and HHS, is a series of prize competitions aimed at accelerating innovation in the prevention, diagnosis, and treatment of kidney diseases.
After hearing many thoughtful comments and concerns from the medical research community, the National Institutes of Health (NIH) announced that it will not implement the proposed Grant Support Index (GSI). The stated goal of the proposed GSI was to improve NIH funding support for early- and mid-career investigators to stabilize the biomedical workforce. However, almost immediately following the announcement of the GSI in May, NIH received an array of comments and concerns from the research community addressing the GSI methodology for assessing research impact, and possible negative effects on collaborative research, complex trials, and research networks.
The COVID-19 pandemic is having a uniquely significant impact on the kidney community: kidney patients are at elevated risk, kidney failure is one of the consequences many people who contract COVID-19 face, and the pandemic has accelerated several trends in kidney medicine, including the prioritization of telehealth and more home-based care. Recognizing these realities, American Society of Nephrology (ASN), and 27 other organizations in the kidney community urged Congressional appropriators to provide emergency supplemental funding for NIDDK and KidneyX to enable a robust and appropriate response.
Nearly 50% of US nephrologists are graduates of international medical schools . These individuals provide critical care in our nation’s teaching hospitals and in areas facing critical physician shortages, fight the COVID-19 pandemic on the front lines, and conduct pioneering research in labs across the country.
ASN and the U.S. Department of Health and Human Services (HHS) have sent a clear signal in their desire to have new therapies in the kidney space through the signing of a Memorandum of Understanding establishing the Kidney Innovation Accelerator (KidneyX), a collaborative environment in which a community of researchers, innovators, and investors can participate. This new public-private partnership aims to prevent future kidney disease, while improving the lives of the 850,000,000 people worldwide who are currently affected by accelerating innovation in the prevention, diagnosis, and treatment of kidney diseases.
The National Institutes of Health Common Fund has recently announced a new funding opportunity from the Human Biomolecular Atlas Program (HuBMAP). HuBMAP aims to accelerate the development of the next generation of tools and techniques to generate 3D tissue maps through an open data platform established in partnership with other funding agencies, programs, and the biomedical research community.